Accuray (ARAY) Capital Expenditures Growth (5y) (2015 - 2026)
Accuray (ARAY) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Accuray | 28,154.86 | -38.51 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.88% |
| Dec 31, 2025 | 48.84% |
| Sep 30, 2025 | -0.28% |
| Mar 31, 2025 | 66.46% |
| Dec 31, 2024 | -49.64% |
| Sep 30, 2024 | -19.07% |
| Mar 31, 2024 | -29.76% |
| Dec 31, 2023 | -27.94% |
| Sep 30, 2023 | -7.38% |
| Mar 31, 2023 | -47.55% |
| Dec 31, 2022 | -23.84% |
| Sep 30, 2022 | 6.49% |
| Mar 31, 2022 | 47.05% |
| Dec 31, 2021 | -15.25% |
| Sep 30, 2021 | 2.31% |
| Mar 31, 2021 | -4.11% |
| Dec 31, 2020 | -25.36% |
| Sep 30, 2020 | -18.10% |
| Jun 30, 2020 | 16.55% |
| Mar 31, 2020 | -33.34% |